<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39381442</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>09</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>10</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">1664-2392</ISSN><JournalIssue CitedMedium="Print"><Volume>15</Volume><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>Frontiers in endocrinology</Title><ISOAbbreviation>Front Endocrinol (Lausanne)</ISOAbbreviation></Journal><ArticleTitle>Association between thyroid function and prognosis of severe COVID-19 among patients with SARS-CoV-2 infection: a retrospective cohort study in China.</ArticleTitle><Pagination><StartPage>1361479</StartPage><MedlinePgn>1361479</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1361479</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fendo.2024.1361479</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="UNASSIGNED">This study aims to examine the thyroid hormone profile and its association with severe coronavirus disease 2019 (COVID-19) in patients infected by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">This retrospective cohort study enrolled patients admitted to a tertiary hospital due to SARS-CoV-2 infection between February 18 and May 18, 2022. Clinical data were collected retrospectively from the electronic medical record system. Based on the thyroid function, patients were divided into five groups: normal, non-thyroid illness syndrome (NTIS), hypothyroidism, thyrotoxicosis, and unclassified. The association between thyroid function and severe COVID-19 was detected using multivariable logistic regression and restricted cubic splines analysis.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">This study included 3,161 patients, with 7.7% of them developing severe COVID-19. 44.9% of the patients had normal thyroid function, 36.5% had NTIS, 6.7% had hypothyroidism, and 1.0% had thyrotoxicosis on admission. After adjusting for age, sex, and relevant clinical characteristics, NTIS and hypothyroidism were associated with increased risks of severe COVID-19 (odds ratio [OR] 2.38, 95% confidence interval [CI] 1.59-3.56 and OR 2.29, 95% CI 1.23-4.26, respectively), compared to normal thyroid function group. Among patients with NTIS or hypothyroidism, higher levels of total triiodothyronine (TT3) are associated with lower risks of severe COVID-19 (OR 0.73, 95% CI 0.64-0.82, for every 0.1nmol/L increase in TT3 level).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">Thyroid hormone profiles of NTIS or hypothyroidism are associated with increased risks of severe COVID-19. The decreased level of TT3 correlated with the increased risk of severe COVID-19 in patients with NTIS or hypothyroidism.</AbstractText><CopyrightInformation>Copyright © 2024 Yang, Qian, Wu, Xu, Qu, Zhou, Liu, Zhu, Wang and Zhao.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Yaling</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Endocrinology, Shanghai Public Health Clinical Center, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Qian</LastName><ForeName>Lifang</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Medicine, Shanghai Qingpu District Zhujiajiao People's Hospital, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Chenwei</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Endocrinology, Shanghai Public Health Clinical Center, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Xinyue</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Endocrinology, Shanghai Public Health Clinical Center, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Qu</LastName><ForeName>Duoduo</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Endocrinology, Shanghai Public Health Clinical Center, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Lihua</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Endocrinology, Shanghai Public Health Clinical Center, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Jia</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Endocrinology, Shanghai Public Health Clinical Center, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhu</LastName><ForeName>Qin</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Department of Endocrinology, Shanghai Public Health Clinical Center, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Chunhong</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Endocrinology, Shanghai Public Health Clinical Center, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Xiaolong</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Endocrinology, Shanghai Public Health Clinical Center, Shanghai, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Endocrinol (Lausanne)</MedlineTA><NlmUniqueID>101555782</NlmUniqueID><ISSNLinking>1664-2392</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D013963">Thyroid Hormones</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002681" MajorTopicYN="N" Type="Geographic">China</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007037" MajorTopicYN="Y">Hypothyroidism</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013961" MajorTopicYN="Y">Thyroid Gland</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013960" MajorTopicYN="N">Thyroid Function Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013971" MajorTopicYN="N">Thyrotoxicosis</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013963" MajorTopicYN="N">Thyroid Hormones</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005067" MajorTopicYN="N">Euthyroid Sick Syndromes</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">non-thyroid illness syndrome</Keyword><Keyword MajorTopicYN="N">severe COVID-19</Keyword><Keyword MajorTopicYN="N">thyroid function</Keyword><Keyword MajorTopicYN="N">total triiodothyronine</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>12</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>9</Day><Hour>10</Hour><Minute>53</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>9</Day><Hour>10</Hour><Minute>52</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>9</Day><Hour>4</Hour><Minute>48</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>1</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39381442</ArticleId><ArticleId IdType="pmc">PMC11458384</ArticleId><ArticleId IdType="doi">10.3389/fendo.2024.1361479</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Puig-Domingo M, Marazuela M, Yildiz BO, Giustina A. COVID-19 and endocrine and metabolic diseases. An updated statement from the European Society of Endocrinology. . Endocrine. (2021) 72:301–16. doi: 10.1007/s12020-021-02734-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12020-021-02734-w</ArticleId><ArticleId IdType="pmc">PMC8105151</ArticleId><ArticleId IdType="pubmed">33963516</ArticleId></ArticleIdList></Reference><Reference><Citation>Brancatella A, Ricci D, Viola N, Sgrò D, Santini F, Latrofa F. Subacute thyroiditis after sars-COV-2 infection. J Clin Endocrinol Metab. (2020) 105:2367–70. doi: 10.1210/clinem/dgaa276</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/clinem/dgaa276</ArticleId><ArticleId IdType="pmc">PMC7314004</ArticleId><ArticleId IdType="pubmed">32436948</ArticleId></ArticleIdList></Reference><Reference><Citation>Brancatella A, Ricci D, Cappellani D, Viola N, Sgrò D, Santini F, et al. . Is subacute thyroiditis an underestimated manifestation of SARS-coV-2 infection? Insights from a case series. J Clin Endocrinol Metab. (2020) 105(10):e3742–6. doi: 10.1210/clinem/dgaa537</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/clinem/dgaa537</ArticleId><ArticleId IdType="pmc">PMC7454668</ArticleId><ArticleId IdType="pubmed">32780854</ArticleId></ArticleIdList></Reference><Reference><Citation>Arefzadeh A. A review of thyroid dysfunction due to COVID-19. Mini Rev Med Chem. (2023) 24(3):265–71. doi: 10.2174/1389557523666230413090332</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1389557523666230413090332</ArticleId><ArticleId IdType="pubmed">37069724</ArticleId></ArticleIdList></Reference><Reference><Citation>Świstek M, Broncel M, Gorzelak-Pabiś P, Morawski P, Fabiś M, Woźniak E. Euthyroid sick syndrome as a prognostic indicator of COVID-19 pulmonary involvement, associated with poorer disease prognosis and increased mortality. Endocr Pract. (2022) 28:494–501. doi: 10.1016/j.eprac.2022.02.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eprac.2022.02.006</ArticleId><ArticleId IdType="pmc">PMC8861257</ArticleId><ArticleId IdType="pubmed">35202790</ArticleId></ArticleIdList></Reference><Reference><Citation>Fliers E, Bianco AC, Langouche L, Boelen A. Thyroid function in critically ill patients. Lancet Diabetes Endocrinol. (2015) 3:816–25. doi: 10.1016/S2213-8587(15)00225-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-8587(15)00225-9</ArticleId><ArticleId IdType="pmc">PMC4979220</ArticleId><ArticleId IdType="pubmed">26071885</ArticleId></ArticleIdList></Reference><Reference><Citation>Sparano C, Zago E, Morettini A, Nozzoli C, Yannas D, Adornato V, et al. . Euthyroid sick syndrome as an early surrogate marker of poor outcome in mild SARS-CoV-2 disease. J Endocrinol Invest. (2022) 45:837–47. doi: 10.1007/s40618-021-01714-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40618-021-01714-1</ArticleId><ArticleId IdType="pmc">PMC8632565</ArticleId><ArticleId IdType="pubmed">34850365</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahn J, Lee MK, Lee JH, Sohn SY. Thyroid hormone profile and its prognostic impact on the coronavirus disease 2019 in korean patients. Endocrinol Metab (Seoul). (2021) 36:769–77. doi: 10.3803/EnM.2021.1109</Citation><ArticleIdList><ArticleId IdType="doi">10.3803/EnM.2021.1109</ArticleId><ArticleId IdType="pmc">PMC8419615</ArticleId><ArticleId IdType="pubmed">34474515</ArticleId></ArticleIdList></Reference><Reference><Citation>Lui DTW, Lee CH, Chow WS, Lee ACH, Tam AR, Fong CHY, et al. . Role of non-thyroidal illness syndrome in predicting adverse outcomes in COVID-19 patients predominantly of mild-to-moderate severity. Clin Endocrinol (Oxf). (2021) 95:469–77. doi: 10.1111/cen.14476</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cen.14476</ArticleId><ArticleId IdType="pmc">PMC8250365</ArticleId><ArticleId IdType="pubmed">33813743</ArticleId></ArticleIdList></Reference><Reference><Citation>Vassiliadi DA, Ilias I, Pratikaki M, Jahaj E, Vassiliou AG, Detsika M, et al. . Thyroid hormone alterations in critically and non-critically ill patients with SARS-CoV-2 infection. Endocr Connect. (2021) 10:646–55. doi: 10.1530/EC-21-0029</Citation><ArticleIdList><ArticleId IdType="doi">10.1530/EC-21-0029</ArticleId><ArticleId IdType="pmc">PMC8240704</ArticleId><ArticleId IdType="pubmed">34010152</ArticleId></ArticleIdList></Reference><Reference><Citation>Wartofsky L, Burman KD. Alterations in thyroid function in patients with systemic illness: the “euthyroid sick syndrome. Endocr Rev. (1982) 3:164–217. doi: 10.1210/edrv-3-2-164</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/edrv-3-2-164</ArticleId><ArticleId IdType="pubmed">6806085</ArticleId></ArticleIdList></Reference><Reference><Citation>Zou R, Wu C, Zhang S, Wang G, Zhang Q, Yu B, et al. . Euthyroid sick syndrome in patients with COVID-19. Front Endocrinol (Lausanne). (2020) 11:566439. doi: 10.3389/fendo.2020.566439</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fendo.2020.566439</ArticleId><ArticleId IdType="pmc">PMC7575767</ArticleId><ArticleId IdType="pubmed">33117282</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao W, Guo W, Guo Y, Shi M, Dong G, Wang G, et al. . Thyroid hormone concentrations in severely or critically ill patients with COVID-19. J Endocrinol Invest. (2021) 44:1031–40. doi: 10.1007/s40618-020-01460-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40618-020-01460-w</ArticleId><ArticleId IdType="pmc">PMC7605732</ArticleId><ArticleId IdType="pubmed">33140379</ArticleId></ArticleIdList></Reference><Reference><Citation>Lang S, Liu Y, Qu X, Lu R, Fu W, Zhang W, et al. . Association between thyroid function and prognosis of COVID-19: A retrospective observational study. Endocr Res. (2021) 46:170–7. doi: 10.1080/07435800.2021.1924770</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/07435800.2021.1924770</ArticleId><ArticleId IdType="pubmed">34014139</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilmar MW, Van den Berghe G. Werner &amp; Ingbar’s the thyroid: a fundamental and clinical text. 10th ed. Philadelphia: Lippincott Williams and Wilkins; (2013) p. 203–17 p.</Citation></Reference><Reference><Citation>Garber JR, Cobin RH, Gharib H, Hennessey JV, Klein I, Mechanick JI, et al. . Clinical practice guidelines for hypothyroidism in adults: cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association. Thyroid. (2012) 22:1200–35. doi: 10.1089/thy.2012.0205</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/thy.2012.0205</ArticleId><ArticleId IdType="pubmed">22954017</ArticleId></ArticleIdList></Reference><Reference><Citation>Ross DS, Burch HB, Cooper DS, Greenlee MC, Laurberg P, Maia AL, et al. . 2016 American thyroid association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis. Thyroid. (2016) 26:1343–421. doi: 10.1089/thy.2016.0229</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/thy.2016.0229</ArticleId><ArticleId IdType="pubmed">27521067</ArticleId></ArticleIdList></Reference><Reference><Citation>Commission NH. Diagnosis and Treatment Plan for Covid-19 (Trial Version 9). China: National Health Commission of the People's Republic of China; (2022).</Citation></Reference><Reference><Citation>Rossetti CL, Cazarin J, Hecht F, Beltrão FEL, Ferreira ACF, Fortunato RS, et al. . COVID-19 and thyroid function: What do we know so far? Front Endocrinol (Lausanne). (2022) 13:1041676. doi: 10.3389/fendo.2022.1041676</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fendo.2022.1041676</ArticleId><ArticleId IdType="pmc">PMC9806267</ArticleId><ArticleId IdType="pubmed">36601011</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng J, Cui Z, Shi N, Tian S, Chen T, Zhong X, et al. . Suppression of the hypothalamic-pituitary-thyroid axis is associated with the severity of prognosis in hospitalized patients with COVID-19. BMC Endocr Disord. (2021) 21:228. doi: 10.1186/s12902-021-00896-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12902-021-00896-2</ArticleId><ArticleId IdType="pmc">PMC8591433</ArticleId><ArticleId IdType="pubmed">34781943</ArticleId></ArticleIdList></Reference><Reference><Citation>Van den Berghe G, de Zegher F, Bouillon R. Clinical review 95: Acute and prolonged critical illness as different neuroendocrine paradigms. J Clin Endocrinol Metab. (1998) 83:1827–34. doi: 10.1210/jcem.83.6.4763</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/jcem.83.6.4763</ArticleId><ArticleId IdType="pubmed">9626104</ArticleId></ArticleIdList></Reference><Reference><Citation>Michalaki M, Vagenakis AG, Makri M, Kalfarentzos F, Kyriazopoulou V. Dissociation of the early decline in serum T(3) concentration and serum IL-6 rise and TNFalpha in nonthyroidal illness syndrome induced by abdominal surgery. J Clin Endocrinol Metab. (2001) 86:4198–205. doi: 10.1210/jcem.86.9.7795</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/jcem.86.9.7795</ArticleId><ArticleId IdType="pubmed">11549650</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilmar MW, Van den Berghe G. Werner &amp; Ingbar’s the thyroid: a fundamental and clinical text. 10th ed. Philadelphia: Lippincott Williams and Wilkins; (2015) p. 203–17 p.</Citation></Reference><Reference><Citation>Holland FW, Brown PS, Weintraub BD, Clark RE. Cardiopulmonary bypass and thyroid function: a “euthyroid sick syndrome. Ann Thorac Surg. (1991) 52:46–50. doi: 10.1016/0003-4975(91)91416-S</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0003-4975(91)91416-S</ArticleId><ArticleId IdType="pubmed">2069461</ArticleId></ArticleIdList></Reference><Reference><Citation>Girvent M, Maestro S, Hernández R, Carajol I, Monné J, Sancho JJ, et al. . Euthyroid sick syndrome, associated endocrine abnormalities, and outcome in elderly patients undergoing emergency operation. Surgery. (1998) 123:560–7. doi: 10.1067/msy.1998.87238</Citation><ArticleIdList><ArticleId IdType="doi">10.1067/msy.1998.87238</ArticleId><ArticleId IdType="pubmed">9591009</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen M, Zhou W, Xu W. Thyroid function analysis in 50 patients with COVID-19: A retrospective study. Thyroid. (2021) 31:8–11. doi: 10.1089/thy.2020.0363</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/thy.2020.0363</ArticleId><ArticleId IdType="pubmed">32600165</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Z, Hou P, Mu S, Wang R, Miao H, Feng M, et al. . Thyroxine changes in COVID-19 pandemic: A systematic review and meta-analysis. Front Endocrinol (Lausanne). (2023) 14:1089190. doi: 10.3389/fendo.2023.1089190</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fendo.2023.1089190</ArticleId><ArticleId IdType="pmc">PMC9969987</ArticleId><ArticleId IdType="pubmed">36860369</ArticleId></ArticleIdList></Reference><Reference><Citation>Moura Neto A, Parisi MC, Alegre SM, Pavin EJ, Tambascia MA, Zantut-Wittmann DE. Relation of thyroid hormone abnormalities with subclinical inflammatory activity in patients with type 1 and type 2 diabetes mellitus. Endocrine. (2016) 51:63–71. doi: 10.1007/s12020-015-0651-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12020-015-0651-5</ArticleId><ArticleId IdType="pubmed">26049370</ArticleId></ArticleIdList></Reference><Reference><Citation>Fallahi P, Elia G, Ragusa F, Paparo SR, Patrizio A, Balestri E, et al. . Thyroid autoimmunity and SARS-coV-2 infection. J Clin Med. (2023) 12(19):6365. doi: 10.3390/jcm12196365</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm12196365</ArticleId><ArticleId IdType="pmc">PMC10573843</ArticleId><ArticleId IdType="pubmed">37835009</ArticleId></ArticleIdList></Reference><Reference><Citation>Boelen A, Platvoet-Ter Schiphorst MC, Wiersinga WM. Association between serum interleukin-6 and serum 3,5,3’-triiodothyronine in nonthyroidal illness. J Clin Endocrinol Metab. (1993) 77:1695–9. doi: 10.1210/jcem.77.6.8263160</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/jcem.77.6.8263160</ArticleId><ArticleId IdType="pubmed">8263160</ArticleId></ArticleIdList></Reference><Reference><Citation>Mebis L, Paletta D, Debaveye Y, Ellger B, Langouche L, D’Hoore A, et al. . Expression of thyroid hormone transporters during critical illness. Eur J Endocrinol. (2009) 161:243–50. doi: 10.1530/EJE-09-0290</Citation><ArticleIdList><ArticleId IdType="doi">10.1530/EJE-09-0290</ArticleId><ArticleId IdType="pubmed">19439506</ArticleId></ArticleIdList></Reference><Reference><Citation>Van den Berghe G, Wouters P, Weekers F, Mohan S, Baxter RC, Veldhuis JD, et al. . Reactivation of pituitary hormone release and metabolic improvement by infusion of growth hormone-releasing peptide and thyrotropin-releasing hormone in patients with protracted critical illness. J Clin Endocrinol Metab. (1999) 84:1311–23. doi: 10.1210/jcem.84.4.5636</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/jcem.84.4.5636</ArticleId><ArticleId IdType="pubmed">10199772</ArticleId></ArticleIdList></Reference><Reference><Citation>Van den Berghe G. Non-thyroidal illness in the ICU: a syndrome with different faces. Thyroid. (2014) 24:1456–65. doi: 10.1089/thy.2014.0201</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/thy.2014.0201</ArticleId><ArticleId IdType="pmc">PMC4195234</ArticleId><ArticleId IdType="pubmed">24845024</ArticleId></ArticleIdList></Reference><Reference><Citation>Grondman I, de Nooijer AH, Antonakos N, Janssen NAF, Mouktaroudi M, Leventogiannis K, et al. . The association of TSH and thyroid hormones with lymphopenia in bacterial sepsis and COVID-19. J Clin Endocrinol Metab. (2021) 106:1994–2009. doi: 10.1210/clinem/dgab148</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/clinem/dgab148</ArticleId><ArticleId IdType="pmc">PMC7989224</ArticleId><ArticleId IdType="pubmed">33713408</ArticleId></ArticleIdList></Reference><Reference><Citation>Lui DTW, Lee CH, Chow WS, Lee ACH, Tam AR, Pang P, et al. . The independent association of TSH and free triiodothyronine levels with lymphocyte counts among COVID-19 patients. Front Endocrinol (Lausanne). (2021) 12:774346. doi: 10.3389/fendo.2021.774346</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fendo.2021.774346</ArticleId><ArticleId IdType="pmc">PMC8792436</ArticleId><ArticleId IdType="pubmed">35095756</ArticleId></ArticleIdList></Reference><Reference><Citation>Sciacchitano S, De Vitis C, D’Ascanio M, Giovagnoli S, De Dominicis C, Laghi A, et al. . Gene signature and immune cell profiling by high-dimensional, single-cell analysis in COVID-19 patients, presenting Low T3 syndrome and coexistent hematological Malignancies. J Transl Med. (2021) 19:139. doi: 10.1186/s12967-021-02805-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-021-02805-6</ArticleId><ArticleId IdType="pmc">PMC8016508</ArticleId><ArticleId IdType="pubmed">33794925</ArticleId></ArticleIdList></Reference><Reference><Citation>Hodkinson CF, Simpson EE, Beattie JH, O’Connor JM, Campbell DJ, Strain JJ, et al. . Preliminary evidence of immune function modulation by thyroid hormones in healthy men and women aged 55-70 years. J Endocrinol. (2009) 202:55–63. doi: 10.1677/JOE-08-0488</Citation><ArticleIdList><ArticleId IdType="doi">10.1677/JOE-08-0488</ArticleId><ArticleId IdType="pubmed">19398496</ArticleId></ArticleIdList></Reference><Reference><Citation>Schoenfeld PS, Myers JW, Myers L, LaRocque JC. Suppression of cell-mediated immunity in hypothyroidism. South Med J. (1995) 88:347–9. doi: 10.1097/00007611-199503000-00019</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00007611-199503000-00019</ArticleId><ArticleId IdType="pubmed">7886534</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>